Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.

Abstract excerpt

Glioblastoma (GBM) is a highly aggressive brain cancer with limited therapeutic options. While efforts to identify genes responsible for GBM have revealed mutations and aberrant gene expression associated with distinct types of GBM, patients with GBM are often diagnosed and classified based on MRI features. Therefore, we seek to identify molecular representatives in parallel with MRI classification for group I...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glioblastoma
• Share to Isocitrate Dehydrogenase